Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Pathology
Erythropoietin factors into growth of gynecological cancers
December 26th, 2002
by Sonia Nichols, senior medical writer - A new investigation suggests erythropoietin accounts for at least some angiogenesis and growth in gynecological tumors. The new finding confirms previous suspicions that erythropoietin and its receptor may contribute to the survival of malignant tumors by influencing capillary growth, according to Yoshiko Yasuda and colleagues at Kinki University School of Medicine in Osaka-Sayama, Japan. Erythropoietin (EPO) stimulates the production of red blood cells. Researchers examined its effects on gynecological malignancies. "To investigate the role of the EPO/EPO receptor pathway in these...
Source: Women's Health Weekly (2002-12-26)
|
